The National Institute of Pharmacy and Nutrition (“OGYÉI”) published new decisions on its webpage concerning pharmaceutical promotional activities and interactions with HCPs. The OGYÉI investigated the commercial practices of Aramis Pharma Kft., Lilly Hungária Kft. and Sager Pharma Kft. and imposed fines due to alleged infringements.
In early March 2020, after COVID-19 had already begun its journey of destruction around the world, the European…
Just a few days after the entry into force of the special tax on retailers (effective as of 1 May 2020), which may amount to as much as 2.5% of their annual turnover, the Hungarian Government further tightened the rules on the distribution of food products by significantly restricting traders’ freedom to negotiate purchase prices.
The financial markets are experiencing a significant amount of disruption for which there is no precedent. However, in these difficult times it is important that originators, sponsors and securitisation special purpose entities (SSPEs) do not lose sight of their regulatory obligations under Regulation (EU) 2017/2402 (Securitisation Regulation). This short briefing…
Countries around the globe are facing unprecedented and rapid change due to the COVID-19 pandemic. The Government Intervention…
Baker McKenzie’s EMEA Employment and Compensation Team is pleased to provide you with this quick guide for employers,…
Read publication Welcome to the October 2019 edition of our newsletter. The EMEA Healthcare Industry Group Newsletter is your regular digest of legal developments affecting the life science and healthcare industries across the region. In this issue: Europe • General presumption of confidentiality of clinical study reports: Opinion of AG…
On October 2, 2019, the World Trade Organization (WTO) issued an arbitration decision in European Communities and Certain…
The EBA outsourcing guidelines came into effect on 30 September 2019. They are more prescriptive than the previous…
As the deadline for the UK’s withdrawal from the EU approaches and there is an increasing risk of a no-deal Brexit, it is vital for companies to understand the impacts of a no deal and how they can address the challenges to their businesses. In this webinar, Baker McKenzie experts…